Compugen (CGEN) Share-based Compensation (2018 - 2021)
Compugen (CGEN) posted quarterly Share-based Compensation of $11.9 million for Q4 2021, up 6.14% year-over-year from $11.2 million in Q4 2020, and up 24.28% on a QoQ basis from $9.6 million in Q2 2021.
Compugen (CGEN) Share-based Compensation (2018 - 2021) Analysis & Trends
Compugen has reported Share-based Compensation for 4 years, with the latest figure at $11.9 million in Q4 2021.
- Share-based Compensation for Q4 2021 came in at $11.9 million, up 6.14% year-over-year; the trailing twelve-month figure through Dec 2021 was $11.9 million (up 6.14% YoY), and the FY2025 annual result was $1.9 million, down 37.78% from the prior year.
- Share-based Compensation grew to $11.9 million in Q4 2021, from $9.6 million in the prior quarter.
- Over five years, Share-based Compensation peaked at $11.9 million in Q4 2021 and troughed at $4.0 million in Q2 2020.
- A 4-year average of $7.0 million and a median of $5.1 million in 2018 frame the typical range for Share-based Compensation.
- The widest annual swing landed in 2019, when Share-based Compensation fell 13.9%; it then jumped 138.94% in 2021.
- A 4-year view of Share-based Compensation shows it stood at $5.2 million in 2018, then dropped by 5.59% to $4.9 million in 2019, then jumped by 127.91% to $11.2 million in 2020, then rose by 6.14% to $11.9 million in 2021.
- Per Business Quant data, the three most recent Share-based Compensation figures were $11.9 million in Q4 2021, $9.6 million in Q2 2021, and $11.2 million in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 108.10 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 243.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 277.20 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 137.41 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 590,899.88 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 86.63 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 41.25 Mn |
| 10 | Compugen | 227.88 Mn | 136.13 Mn | 352,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 11.93 Mn |
| Dec 31, 2021 | 11.93 Mn |
| Jun 30, 2021 | 9.60 Mn |
| Jun 30, 2021 | 9.60 Mn |
| Dec 31, 2020 | 11.24 Mn |
| Dec 31, 2020 | 11.24 Mn |
| Jun 30, 2020 | 4.02 Mn |
| Jun 30, 2020 | 4.02 Mn |
| Dec 31, 2019 | 4.93 Mn |
| Dec 31, 2019 | 4.93 Mn |
| Jun 30, 2019 | 4.20 Mn |
| Jun 30, 2019 | 4.20 Mn |
| Dec 31, 2018 | 5.22 Mn |
| Dec 31, 2018 | 5.22 Mn |
| Jun 30, 2018 | 4.88 Mn |
| Jun 30, 2018 | 4.88 Mn |